Disclosures for "Reteplase Versus Alteplase for Acute Ischemic Stroke: Meta-analysis"
-
Mr. Alkhiri has nothing to disclose.
-
Dr. Aldriweesh has nothing to disclose.
-
Mr. Salamatullah has nothing to disclose.
-
Mr. Alturki has nothing to disclose.
-
Mr. Alamri has nothing to disclose.
-
Mr. Almaghrabi has nothing to disclose.
-
Mr. Alshaikh has nothing to disclose.
-
Dr. Nguyen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vesalio. Dr. Nguyen has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Nguyen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avania. Dr. Nguyen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AHA. The institution of Dr. Nguyen has received research support from Boston Medical Center. The institution of Dr. Nguyen has received research support from Society of Vascular and Interventional Neurology.
-
Dr. Al-Ajlan has nothing to disclose.
-
Dr. Alhazzani has nothing to disclose.